{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:11:52Z","timestamp":1761898312423,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clinre.2015.05.015","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T21:41:49Z","timestamp":1437169309000},"page":"S41-S45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Therapeutic management of alcoholic hepatitis"],"prefix":"10.1016","volume":"39","author":[{"given":"Philippe","family":"Mathurin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2015.05.015_bib0190","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0200","first-page":"18","article-title":"Expression and immunological reactivity of recombinant HCV-core protein","volume":"8","author":"Dai","year":"2000","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.clinre.2015.05.015_bib0205","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/j.1572-0241.2008.02104.x","article-title":"A new scoring system for prognostic stratification of patients with alcoholic hepatitis","volume":"103","author":"Dominguez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0215","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.05.015_bib0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0230","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/gut.37.1.113","article-title":"Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables","volume":"37","author":"Christensen","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.05.015_bib0235","doi-asserted-by":"crossref","first-page":"299","DOI":"10.7326\/0003-4819-113-4-299","article-title":"Do corticosteroids reduce mortality from alcoholic hepatitis?","volume":"113","author":"Imperiale","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0240","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1111\/j.1572-0241.1999.03066.x","article-title":"Corticosteroids are effective in patients with severe alcoholic patients","volume":"94","author":"Imperiale","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0245","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-136-12-200206180-00010","article-title":"Truth survival in clinical research: an evidence based requiem?","volume":"136","author":"Poynard","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0250","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.05.015_bib0255","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels (ECBL) is an important prognostic factor in severe biopsy-proven alcoholic hepatitis (AH) treated by prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0260","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0265","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Prospective screening of infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0270","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0275","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","author":"European Association for the Study of Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0280","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ajg.2009.593","article-title":"Alcoholic liver disease","volume":"105","author":"O'Shea","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0285","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","article-title":"Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial","volume":"61","author":"Park","year":"2014","journal-title":"J Hepatol"},{"issue":"S1","key":"10.1016\/j.clinre.2015.05.015_bib0290","first-page":"LB1","article-title":"Steroids or pentoxifylline for alcoholic hepatitis: results of the STOPAH trial","volume":"60","author":"Thursz","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0295","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs. without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2015.05.015_bib0300","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0315","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0320","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.015_bib0325","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0330","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis \u2013\u00a0a randomised clinical trial","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0335","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.clinre.2015.05.015_bib0340","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1002\/lt.20247","article-title":"Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era","volume":"10","author":"Olthoff","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2015.05.015_bib0345","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(06)68904-6","article-title":"Recommendations for alcohol-related liver disease","volume":"367","author":"Bathgate","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2015.05.015_bib0350","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0168-8278(02)00086-7","article-title":"Is liver transplantation an appropriate treatment for acute alcoholic hepatitis?","volume":"36","author":"Lucey","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.015_bib0355","first-page":"S51","article-title":"Transplantation for alcoholic liver disease: a survey from Europe","volume":"4","author":"Neuberger","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.clinre.2015.05.015_bib0360","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1053\/jlts.2001.25361","article-title":"Allocation of transplantation organs: do people want to punish patients for causing their illness?","volume":"7","author":"Ubel","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinre.2015.05.015_bib0365","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2015.05.015_bib0370","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMe1110864","article-title":"Transplantation for alcoholic hepatitis \u2013\u00a0time to rethink the 6-month \u201crule\u201d","volume":"365","author":"Brown","year":"2011","journal-title":"N Engl J Med"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:43Z","timestamp":1761895303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740115001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":37,"alternative-id":["S2210740115001266"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2015.05.015","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic management of alcoholic hepatitis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2015.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}